Dr. Jeffrey D. Browning, MD

Dr. Browning practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Browning's NPI, 1871550285, was assigned on April 28, 2006. Dr. Browning graduated from UT Southwestern Medical Center in 1998. Dr. Browning holds Texas license L1535.

Dr. Browning's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Browning's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Browning to 1 more clinical lab, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Browning practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Browning's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Browning is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Browning's licenses on file in 2 states: Texas and Alabama.

Dmand AI lists colonoscopy among the conditions Dr. Browning treats.

CMS data shows 19 Medicare services from Dr. Browning across 1 procedure code in 2021, for 32 Medicare patients. Medicare paid $1,453 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Dr. Browning in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Browning's median patient age at 62, with 38% women.

In 2020, Dr. Browning wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $180 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Browning for performance year 2024, reported as part of a group. Dr. Browning accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 65 papers to Dr. Browning, published from 2006 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Liver, Fatty Liver and Gluconeogenesis. Dr. Browning has published most often in Hepatology. Dr. Browning's most frequent co-authors are Craig Riggs Malloy, MD, Jay D. Horton, MD and Justin Fletcher, MD.

Dmand AI links Dr. Browning to 3 clinical trials. Conditions studied include Hypoalbuminemia, Lipodystrophy and Non-alcoholic Fatty Liver Disease. University of Texas Southwestern Medical Center sponsors the most, 3.

CMS Open Payments shows 4 general payments to Dr. Browning from 3 drug and device companies from 2018 to 2023. Consulting fees make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $5,250.

Dmand AI lists 11 awards for Dr. Browning, most recently Margo A. Denke M.D. Professor in Clinical Nitrition Research in 2023.

Dr. Browning graduated from UT Southwestern Medical Center in 1998. Dr. Browning is a member of American Association for the Study of Liver Disease.

Dr. Browning is in network with 24 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.